Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
for
Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: Female
Age: 18+
Code: NCT06405828
Recruiting
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
for
Breast Cancer Female, Early-stage Breast Cancer,
Location: Montreal
Sponsor: Jewish General Hospital
Sex: Female
Age: 18+
Code: NCT04671511
Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Portland ME, Waterbury CT, Mineola NY, Mount Kisco NY,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
for
Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06439693
Phase2, Recruiting
Interested in new breast cancer trials?
Get alerts for new trials in your area by subscribing now
Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 0+
Code: NCT04428528
Recruiting
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
for
Breast Cancer, Breast Carcinoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT05716893
Phase2, Recruiting
Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer
for
Breast Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Female
Age: 18+
Code: NCT04050228
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
for
Metastatic Breast Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06110793
Phase1, Phase2, Recruiting
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
for
Breast Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT06258993
Recruiting
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06260033
Phase2, Recruiting
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
for
Breast Cancer
Location: Houston TX, Dallas TX
Sponsor: ARTIDIS AG
Sex: All
Age: 18+
Code: NCT06085833
Recruiting
Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer
for
Breast Cancer, Prostate Cancer, Vertebral Metastasis, Pain
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 35 - 70+
Code: NCT00294151
Phase3, Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: New Haven CT, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05867251
Phase1, Phase2, Recruiting
A Study of Mental Health Care in People With Cancer
for
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 65+
Code: NCT06037954
Recruiting
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT04526587
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Cognitive Rehabilitation Following Breast Cancer Treatment